Showing results (1231-1240 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|November 25, 2010
HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacyKatja Berginc, Tina Trdan, Jurij Trontelj, et al.Biopharmaceutics & Drug Disposition|November 25, 2010
Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cellsMohammad M Al-Bataineh, Deon van der Merwe, Bruce D Schultz, et al.Biopharmaceutics & Drug Disposition|October 1, 1990
Pharmacokinetics of pafenolol in the rat: a suitable model for studying absorption mechanisms of a drug exhibiting unusual absorption properties in manH Lenneräs, C G RegårdhBiopharmaceutics & Drug Disposition|March 23, 2007
Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailabilityHye J Chung, Joo H Lee, Sung J Woo, et al.Biopharmaceutics & Drug Disposition|March 23, 2007
Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipientsMasatomo Miura, Kazuyuki Inoue, Hideaki Kagaya, et al.Biopharmaceutics & Drug Disposition|October 18, 2007
Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipientsLi-Yan Miao, Chen-Rong Huang, Jian-Quan Hou, et al.Biopharmaceutics & Drug Disposition|June 16, 2007
Dose-proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteersArthur Bergman, Goutam C Mistry, Wen-Lin Luo, et al.Biopharmaceutics & Drug Disposition|June 19, 2007
Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteersArthur Bergman, David Ebel, Fang Liu, et al.Biopharmaceutics & Drug Disposition|November 6, 2008
Pharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeysYu Du, Hong Tian, Xiang-Dong Gao, et al.Biopharmaceutics & Drug Disposition|April 5, 2012
Comparative transcutaneous immunization with imiquimod-containing ointments and potential of in vitro methods to predict effectsKarsten Gogoll, Pamela Stein, Hai Wei, et al.Pageof 214